Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
12/06/202420:56Alliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
12/06/202420:56Alliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
12/06/202415:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
10/06/202408:30Alliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
10/06/202408:30Alliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
05/06/202409:27Alliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
05/06/202409:27Alliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
05/06/202407:00RNS Regulatory NewsAstraZeneca PLC Acquisition of Fusion completedLSE:AZNAstrazeneca Plc
04/06/202412:00PR Newswire (US)AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024LSE:AZNAstrazeneca Plc
03/06/202415:05RNS Regulatory NewsAstraZeneca PLC Block listing Interim ReviewLSE:AZNAstrazeneca Plc
03/06/202415:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
03/06/202408:59Alliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
03/06/202408:59Alliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
03/06/202407:00RNS Regulatory NewsAstraZeneca PLC Tagrisso plus chemo recommended for approval in EULSE:AZNAstrazeneca Plc
29/05/202408:54Alliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
29/05/202408:54Alliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
28/05/202407:00RNS Regulatory NewsAstraZeneca PLC Dato-DXd improved OS in nonsquamous lung cancerLSE:AZNAstrazeneca Plc
27/05/202407:49Alliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
27/05/202407:49Alliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
21/05/202412:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202412:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202408:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202408:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202407:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030LSE:AZNAstrazeneca Plc
20/05/202408:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202408:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202407:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to manufacture ADCs in SingaporeLSE:AZNAstrazeneca Plc
16/05/202410:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202410:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202407:00RNS Regulatory NewsAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention endpointLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN